Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Post by JDavenporton Nov 25, 2022 10:22am
228 Views
Post# 35128017

New Update of SH System Update

New Update of SH System UpdateStochouse has again updated their new enforcement policies and strategies.

It's quite ambitious and I hope it works, but it may produce somewhat sterile and occasionally annoying posting and reading experiences. 

I wish good fortune to all of you who will not be following me elsewhere. I may post here from time to time, strictly on topic, but I'm not interested in dealing with Stockhouse censors and trolls at the same time.

jd
<< Previous
Bullboard Posts
Next >>